Cargando…

Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US

BACKGROUND AND OBJECTIVES: The burden imposed by cardiovascular disease (CVD) on patients with type 1 diabetes (T1D) in the US has not been thoroughly addressed. In a retrospective observational analysis of the Optum(®) Clinformatics™ Data Mart database, the prevalence of CVD and cardiovascular risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelman, Steve, Zhou, Fang Liz, Preblick, Ronald, Verma, Sumit, Paranjape, Sachin, Davies, Michael J., Joish, Vijay N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426334/ https://www.ncbi.nlm.nih.gov/pubmed/31997126 http://dx.doi.org/10.1007/s41669-019-00192-9

Ejemplares similares

Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States
por: Joish, Vijay N., et al.
Publicado: (2020)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record database
por: Pettus, Jeremy H., et al.
Publicado: (2019)

Burden of Complications in U.S. Adults With Young-Onset Type 2 or Type 1 Diabetes
por: Fang, Michael, et al.
Publicado: (2020)

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin
por: Zhou, Fang Liz, et al.
Publicado: (2018)

Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin
por: Meneghini, Luigi F., et al.
Publicado: (2018)

Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
por: Edelman, Steven, et al.
Publicado: (2023)

Subclinical Cardiovascular Disease in US Adults With and Without Diabetes
por: Fang, Michael, et al.
Publicado: (2023)

Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study
por: Sullivan, Sean D., et al.
Publicado: (2018)

Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study
por: Kulke, Matthew H, et al.
Publicado: (2021)

Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
por: Anderson, Peter, et al.
Publicado: (2021)

Trends in cardiovascular burden and mortality among adults with prediabetes in the US, 1999–2018
por: Zhang, Yi, et al.
Publicado: (2023)

Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures
por: Pettus, Jeremy H., et al.
Publicado: (2019)

MON-630 Elevating the Patient Voice in Type 1 Diabetes Clinical Trials: A Comparison of In-Depth Exit Interviews and Diabetes-Specific Questionnaires
por: Ervin, Claire, et al.
Publicado: (2020)

Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia
por: Heresi, Gustavo A., et al.
Publicado: (2017)

Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis
por: Poirrier, Jean-Etienne, et al.
Publicado: (2022)

The Burden of Cardiovascular Diseases Among US States, 1990-2016
por: Roth, Gregory A., et al.
Publicado: (2018)

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps
por: Bhattacharyya, Neil, et al.
Publicado: (2019)

Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study
por: Bailey, Timothy S., et al.
Publicado: (2019)

Cardiovascular factors moderate the association of infection burden with cognitive function in young to middle-aged U.S. adults
por: Hedges, Dawson W., et al.
Publicado: (2019)

Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)
por: Evans, Marc, et al.
Publicado: (2022)

Direct costs of carcinoid syndrome diarrhea among adults in the United States
por: Dasari, Arvind, et al.
Publicado: (2019)

Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL
por: Dailey, George, et al.
Publicado: (2018)

Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023)

Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study
por: Chauhan, Ankita, et al.
Publicado: (2023)

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
por: Fang, Michael, et al.
Publicado: (2021)

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data
por: Davidson, Jaime A., et al.
Publicado: (2020)

Cardiovascular Disease Risk Factors in US Adults With Vision Impairment
por: Mendez, Isabel, et al.
Publicado: (2022)

Evaluation of anti-diabetic activity of Glucova Active Tablet on Type I and Type II diabetic model in rats
por: Soni, Hardik, et al.
Publicado: (2014)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents
por: Boye, Kristina S., et al.
Publicado: (2020)

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey
por: Berard, Lori, et al.
Publicado: (2017)

Cardiovascular and diabetes burden attributable to physical inactivity in Mexico
por: Medina, Catalina, et al.
Publicado: (2020)

Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence
por: Boyle, James P, et al.
Publicado: (2010)

Changes Over Time in High Out-of-Pocket Health Care Burden in U.S. Adults With Diabetes, 2001–2011
por: Li, Rui, et al.
Publicado: (2014)

Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: An ideal facility
por: Jain, Archana, et al.
Publicado: (2013)

Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries
por: Glantz, Namino M., et al.
Publicado: (2019)

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study
por: Gupta, Shaloo, et al.
Publicado: (2018)

Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults
por: Hirode, Grishma, et al.
Publicado: (2020)

Birth Cohort Differences in Multimorbidity Burden Among Aging U.S. Adults
por: Bishop, Nicholas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h6aq1vstmmjec0bh0rl5p9tjqd